Atlas Trials

Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

Clinical trial NCT05369078 · UNKNOWN

Trial details

NCT number
NCT05369078
Sponsor
Newsoara Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2021-12-01
Primary completion
2022-05-31
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.